Mark Stanley Berger serves as Executive at Actinium Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Mark Stanley Berger has executed 7 insider transactions totaling $5.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 22, 2025 involved receiving (via award) 28,500 shares valued at $0.
Mark Stanley Berger currently holds 28,860 shares of Actinium Pharmaceuticals, Inc. (ATNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Stanley Berger has been a net buyer of ATNM stock. They have purchased $5.5K and sold $0 worth of shares.
Mark Stanley Berger's most recent insider trade was on Dec 22, 2025, when they sold 28,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.23 |
| Discretionary |
| Feb 18, 2024 | GNPX | $5.8K | Payment | 1,319 | $4.40 | Discretionary |
| Feb 18, 2023 | GNPX | $0 | Award | 245,000 | $N/A | Discretionary |
| Mar 5, 2019 | ATNM | $2.1K | Exercise | 3,500 | $0.60 | Discretionary |
| Mar 6, 2018 | ATNM | $7.0K | Other | 14,000 | $0.50 | Discretionary |
| Jun 15, 2017 | ATNM | $5.5K | Purchase | 5,000 | $1.11 | Discretionary |